2000
Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer
Farrow D, Vaughan T, Sweeney C, Gammon M, Chow W, Risch H, Stanford J, Hansten P, Mayne S, Schoenberg J, Rotterdam H, Ahsan H, West A, Dubrow R, Fraumeni J, Blot W. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes & Control 2000, 11: 231-238. PMID: 10782657, DOI: 10.1023/a:1008913828105.Peer-Reviewed Original ResearchConceptsGastroesophageal reflux diseaseNon-cardia gastric adenocarcinomaEsophageal adenocarcinomaGERD symptomsReflux diseaseH2 blockersGastric adenocarcinomaGastric cancerLarge population-based case-control studyPopulation-based case-control studyPopulation-based tumor registryEsophageal squamous cell carcinomaPerson structured interviewRisk of esophagealSquamous cell carcinomaEsophageal adenocarcinoma riskH2-receptor antagonistsCase-control studyGastric cardia adenocarcinomaRandom digit dialingLong-term usersTumor RegistryAdenocarcinoma riskDaily symptomsCell carcinoma
1998
Sunlamp use and the risk of cutaneous malignant melanoma: a population-based case-control study in Connecticut, USA
Chen Y, Dubrow R, Zheng T, Barnhill R, Fine J, Berwick M. Sunlamp use and the risk of cutaneous malignant melanoma: a population-based case-control study in Connecticut, USA. International Journal Of Epidemiology 1998, 27: 758-765. PMID: 9839730, DOI: 10.1093/ije/27.5.758.Peer-Reviewed Original ResearchConceptsCutaneous malignant melanomaSunlamp useMalignant melanomaHigh riskPopulation-based case-control studyFirst primary cutaneous melanomaRecreational sun exposurePrimary cutaneous melanomaCase-control studyRisk of melanomaUse of sunlampsRandom digit dialingCutaneous melanomaSubgroup analysisSun exposureCutaneous phenotypeGeneral populationStudy subjectsMelanomaLimited evidenceCaucasian populationFirst useRiskSunlampsAmount of exposure